An interesting feature we have observed in this study was that the highest frequencies of anti-TAAs antibody were 26.8% (anti-cyclin B1) in gastric cancer and 25.5% (anti-p53) in lung cancer. This evidence concerns the gene TP53 and lung carcinoma.